Substance / Medication

Pyrantel pamoate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Macrocyclic lactone-resistant Parascaris equorum on stud farms in Canada and effectiveness of fenbendazole and pyrantel pamoate.
Slocombe J Owen D, de Gannes Rolph V G, Lake Mary C · Vet Parasitol · 2007
PMID: 16962243RCT
Dose-confirmation studies of the cestocidal activity of pyrantel pamoate paste in horses.
Reinemeyer Craig R, Hutchens Douglas E, Eckblad Wm P et al. · Vet Parasitol · 2006
PMID: 16530970RCT
Target animal safety and tolerance study of pyrantel pamoate paste (19.13% w/w pyrantel base) administered orally to horses.
Marchiondo Alan A, TerHune Terry N, Herrick Robert L · Vet Ther · 2005
PMID: 16550493RCT
Efficacy of pyrantel pamoate and ivermectin paste formulations against naturally acquired Oxyuris equi infections in horses.
Reinemeyer Craig R, Prado Julio C, Nichols Eric C et al. · Vet Parasitol · 2010
PMID: 20307935Observational
An ocular myasthenia gravis attack after oral pyrantel pamoate: An unusual case report.
Shen Chaolan, Li Min, Zhao Xin et al. · Medicine (Baltimore) · 2019
PMID: 31277177Case ReportFull text (PMC)
Massive proteinuria: a possible side effect of pyrantel pamoate?
Ferrara Pietro, Bersani Iliana, Bottaro Giorgia et al. · Ren Fail · 2011
PMID: 21500989Case Report
[Albendazole in Japanese juvenile with enterobiasis in whom pyrantel pamoate is not effective].
Ohnishi Kenji, Kobayashi Ken-ichiro, Iwabuchi Sentaro et al. · Kansenshogaku Zasshi · 2011
PMID: 22117382Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pyrantel pamoate (substance)
SNOMED CT
25013003
UMLS CUI
C0034237

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.